Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eton Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ETON
Nasdaq
2830
www.etonpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
- Feb 6th, 2025 11:50 am
New Strong Buy Stocks for January 28th
- Jan 28th, 2025 11:20 am
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum
- Jan 25th, 2025 2:15 pm
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
- Jan 24th, 2025 9:17 am
Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now
- Jan 15th, 2025 6:46 pm
Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain
- Jan 9th, 2025 11:57 am
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
- Jan 3rd, 2025 11:50 am
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
- Dec 20th, 2024 11:50 am
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
- Dec 17th, 2024 11:50 am
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions
- Dec 12th, 2024 4:23 pm
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
- Dec 3rd, 2024 11:50 am
Eton acquires US rights to neonatal diabetes treatment from AMMTeK
- Nov 26th, 2024 2:48 pm
Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK
- Nov 26th, 2024 11:55 am
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
- Nov 25th, 2024 11:50 am
Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
- Nov 15th, 2024 12:59 pm
Q3 2024 Eton Pharmaceuticals Inc Earnings Call
- Nov 13th, 2024 12:09 pm
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
- Nov 13th, 2024 7:18 am
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
- Nov 12th, 2024 9:01 pm
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
- Nov 7th, 2024 12:00 pm
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
- Nov 6th, 2024 9:30 pm
Scroll